BSECompany Update9h ago · 4 Sept 2026, 04:40 pm
Investors Conference - 14th September 2026
Sai Life Sciences Ltd · 544306
✦ AI SummaryMgmt Change
Sai Life Sciences Ltd has announced an investors conference on September 14th, 2026, as part of the 24th Annual Global Healthcare Conference in New York. The meeting will be held in-person and will be based on publicly available information, with no unpublished price-sensitive information to be shared.
Analysis Scores
Earnings Impact2/10
Growth Catalyst3/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Sai Life Sciences Ltd - 544306 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
87c6b1f4-c258-490a-bce3-f2a6c3cf7ca8.pdf
View document text
04th September 2026
To To
The Listing Department, The Corporate Relations Department,
National Stock Exchange of India Limited BSE Limited
NSE Symbol: SAILIFE BSE Scrip code: 544306
Dear Sir/Madam,
Ref: Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations,
2015 (“SEBI Listing Regulations”)
Sub: Intimation of schedule of Analyst / Institutional Investor Meeting.
Pursuant to Regulation 30 read with Schedule III of SEBI Listing Regulations we hereby
inform you that the officials of the Company will be attending Annual Global Healthcare
Conference as per the details below:
Date / Time of Analysts / Institutional Type / Mode of Venue of the
Meeting Investors / Organisation the Meeting Meeting
Monday, 14th Morgan Stanley - 24th Annual Group / One-on- New York
September 2026 from Global Healthcare Conference One (In-person)
09:00 A.M. to 06:00
P.M. (EST)
Note:
1. Discussions will be based on publicly available information and No Unpublished Price
Sensitive Information will be shared during the meetings.
2. The Schedule of the above Analyst / Institutional Investor Meeting is subject to change.
The change may happen due to exigencies on the part of Participants / Company.
3. Investors / Analysts may also subsequently approach the Company for any clarifications
regarding the discussion during the aforesaid meeting.
The above information is also available on the website of the Company:
https://sailife.com/disclosures/.
Kindly take the above information on your record.
Thanking you.
Yours sincerely,
For Sai Life Sciences Limited
Runa Karan
Company Secretary & Compliance Officer
Membership No. A13721
Sai Life Sciences Limited (CIN: L24110TG1999PLC030970)
Corporate office Registered office Contact us
T: +91 40 6815 6000,
# L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally
F: +91 40 6815 6199
#133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri
E: info@sailife.com
Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India.
W: www.sailife.com
Telangana, India.